Stay updated on Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe page header revision was updated from v3.5.4 to v3.5.5, reflecting a minor metadata update to the study page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a small version bump rather than a substantive change to the study information.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new 2026 publication citation about nemolizumab in atopic dermatitis is now listed in Publications, and the prior 2025 'Online ahead of print' citation has been removed.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, indicating a new revision of the page content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.